<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>BioMed Central</PublisherName>
    <PublisherLocation>London</PublisherLocation>
    <PublisherImprintName>BioMed Central</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="Online">
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>13578</JournalID>
      <JournalElectronicISSN>2045-3701</JournalElectronicISSN>
      <JournalTitle>Cell &amp; Bioscience</JournalTitle>
      <JournalAbbreviatedTitle>Cell Biosci</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCL" Type="Primary">Life Sciences</JournalSubject>
        <JournalSubject Code="SCL16008" Priority="1" Type="Secondary">Cell Biology</JournalSubject>
        <JournalSubject Code="SCL23004" Priority="2" Type="Secondary">Microbiology</JournalSubject>
        <JournalSubject Code="SCL16010" Priority="3" Type="Secondary">Stem Cells</JournalSubject>
        <JournalSubject Code="SCL25066" Priority="4" Type="Secondary">Neurobiology</JournalSubject>
        <JournalSubject Code="SCL1403X" Priority="5" Type="Secondary">Proteomics</JournalSubject>
        <SubjectCollection Code="Biomedical and Life Sciences">SC3</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="Online">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>6</VolumeIDStart>
        <VolumeIDEnd>6</VolumeIDEnd>
        <VolumeIssueCount>1</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="Online">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>0</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2016</Year>
              <Month>12</Month>
            </CoverDate>
            <PricelistYear>2016</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>The Author(s)</CopyrightHolderName>
            <CopyrightYear>2016</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s13578-016-0108-4" OutputMedium="Online">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="Yes" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>108</ArticleID>
            <ArticleDOI>10.1186/s13578-016-0108-4</ArticleDOI>
            <ArticleCitationID>41</ArticleCitationID>
            <ArticleSequenceNumber>41</ArticleSequenceNumber>
            <ArticleTitle Language="En" OutputMedium="All">Disruption of the Golgi protein <Emphasis Type="Italic">Otg1</Emphasis> gene causes defective hormone secretion and aberrant glucose homeostasis in mice</ArticleTitle>
            <ArticleCategory>Research</ArticleCategory>
            <ArticleFirstPage>1</ArticleFirstPage>
            <ArticleLastPage>10</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>1</Day>
              </RegistrationDate>
              <Received>
                <Year>2016</Year>
                <Month>5</Month>
                <Day>12</Day>
              </Received>
              <Accepted>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>2</Day>
              </Accepted>
              <OnlineDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>10</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleFundingInformation>
              <Fund>
                <FunderName>Chinese Hi-tech Research and Development Project</FunderName>
                <GrantNumber GrantRecipient="Au8" Type="FundRef">2014AA021104</GrantNumber>
              </Fund>
              <Fund>
                <FunderName FundRefID="http://dx.doi.org/10.13039/501100001809">National Natural Science Foundation of China</FunderName>
                <GrantNumber GrantRecipient="Au8" Type="FundRef">81570756</GrantNumber>
                <GrantNumber GrantRecipient="Au8" Type="FundRef">81170789</GrantNumber>
              </Fund>
              <Fund>
                <FunderName>Shanghai Municipal Government</FunderName>
                <GrantNumber GrantRecipient="Au8" Type="FundRef">15XD1500500</GrantNumber>
                <GrantNumber GrantRecipient="Au8" Type="FundRef">12431900100</GrantNumber>
              </Fund>
            </ArticleFundingInformation>
            <ArticleCopyright>
              <CopyrightHolderName>The Author(s)</CopyrightHolderName>
              <CopyrightYear>2016</CopyrightYear>
              <License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0">
                <SimplePara>
                           <Emphasis Type="Bold">Open Access</Emphasis>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ExternalRef>
                    <RefSource>http://creativecommons.org/licenses/by/4.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/>
                  </ExternalRef>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ExternalRef>
                    <RefSource>http://creativecommons.org/publicdomain/zero/1.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/>
                  </ExternalRef>) applies to the data made available in this article, unless otherwise stated.</SimplePara>
              </License>
            </ArticleCopyright>
            <ArticleGrants Type="OpenChoice">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="OpenAccess"/>
              <BodyHTMLGrant Grant="OpenAccess"/>
              <BibliographyGrant Grant="OpenAccess"/>
              <ESMGrant Grant="OpenAccess"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" EqualContribution="Yes" ID="Au1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Guangxue</GivenName>
                  <FamilyName>Wang</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>guangxue_wang@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" EqualContribution="Yes" ID="Au2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Rongbo</GivenName>
                  <FamilyName>Li</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>rongboli@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" EqualContribution="Yes" ID="Au3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Ying</GivenName>
                  <FamilyName>Yang</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>12307110380@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" ID="Au4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Liang</GivenName>
                  <FamilyName>Cai</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>cail@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff2" ID="Au5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Sheng</GivenName>
                  <FamilyName>Ding</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>sheng_ding@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1 Aff2" ID="Au6">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tian</GivenName>
                  <FamilyName>Xu</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>tian.xu@yale.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1 Aff3" ID="Au7">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Min</GivenName>
                  <FamilyName>Han</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>mhan@colorado.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au8" ORCID="http://orcid.org/0000-0002-1801-9645">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Xiaohui</GivenName>
                  <FamilyName>Wu</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>xiaohui_wu@fudan.edu.cn</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>State Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center for Genetics and Development, School of Life Sciences</OrgDivision>
                <OrgName>Fudan University</OrgName>
                <OrgAddress>
                  <City>Shanghai</City>
                  <Postcode>200433</Postcode>
                  <Country Code="CN">China</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Howard Hughes Medical Institute, Department of Genetics</OrgDivision>
                <OrgName>Yale University School of Medicine</OrgName>
                <OrgAddress>
                  <City>New Haven</City>
                  <State>CT</State>
                  <Postcode>06536</Postcode>
                  <Country Code="US">USA</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgDivision>Howard Hughes Medical Institute, Department of Molecular, Cellular and Developmental Biology</OrgDivision>
                <OrgName>University of Colorado</OrgName>
                <OrgAddress>
                  <City>Boulder</City>
                  <State>CO</State>
                  <Postcode>80309</Postcode>
                  <Country Code="US">USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Background</Heading>
                <Para ID="Par1">Concerted hormone secretion is essential for glucose homeostasis and growth. The oocyte testis gene 1 (<Emphasis Type="Italic">Otg1</Emphasis>) has limited information in mammals before. Human OTG1 has been identified as an antigen associated with cutaneous T cell lymphoma, while worm <Emphasis Type="Italic">Otg1</Emphasis> is recently reported to be a vesicle trafficking regulator in neurons. To understand the physiological role of <Emphasis Type="Italic">Otg1</Emphasis> and its potential relation to hormone secretion, we characterized a mutation caused by the <Emphasis Type="Italic">piggyBac</Emphasis> transposon (<Emphasis Type="Italic">PB</Emphasis>) insertion in mice.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Results</Heading>
                <Para ID="Par2">Oocyte testis gene 1 encodes a Golgi localized protein that is expressed with a broad tissue distribution in mice. The <Emphasis Type="Italic">PB</Emphasis> insertion effectively blocks <Emphasis Type="Italic">Otg1</Emphasis> expression, which results in postnatal lethality, growth retardation, hypoglycemia and improved insulin sensitivity in mice. <Emphasis Type="Italic">Otg1</Emphasis> mutants exhibit decreased levels of insulin, leptin and growth hormone in the circulation and reduced hepatic IGF-1 expression. Decreased expression of <Emphasis Type="Italic">Otg1</Emphasis> in pituitary GH3 cells causes reduced grow hormone expression and secretion, as well as the traffic of the VSVG protein marker.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Conclusions</Heading>
                <Para ID="Par3">Our data support the hypothesis that <Emphasis Type="Italic">Otg1</Emphasis> impacts hormone secretion by regulating vesicle trafficking. These results revealed a previously unknown and important role of <Emphasis Type="Italic">Otg1</Emphasis> in hormone secretion and glucose homeostasis in mammals.</Para>
              </AbstractSection>
            </Abstract>
            <KeywordGroup Language="En" OutputMedium="All">
              <Heading>Keywords</Heading>
              <Keyword>
                <Emphasis Type="Italic">Otg1</Emphasis>
              </Keyword>
              <Keyword>Hypoglycemia</Keyword>
              <Keyword>Hypoinsulinemia</Keyword>
              <Keyword>Vesicle trafficking</Keyword>
            </KeywordGroup>
            <AbbreviationGroup>
              <Heading>Abbreviations</Heading>
              <DefinitionList>
                <DefinitionListEntry>
                  <Term>CTCL</Term>
                  <Description>
                    <Para ID="Par4">cutaneous T-cell lymphoma</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GH</Term>
                  <Description>
                    <Para ID="Par5">growth hormone</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GHR</Term>
                  <Description>
                    <Para ID="Par6">growth hormone receptor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GSIS</Term>
                  <Description>
                    <Para ID="Par7">islet culture and glucose stimulated insulin secretion</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GTT</Term>
                  <Description>
                    <Para ID="Par8">glucose tolerant test</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>IDM</Term>
                  <Description>
                    <Para ID="Par9">The Institute of Developmental Biology and Molecular Medicine</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>IPGTT</Term>
                  <Description>
                    <Para ID="Par10">intraperitoneal glucose tolerance test</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>ITT</Term>
                  <Description>
                    <Para ID="Par11">insulin tolerance test</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>MEF</Term>
                  <Description>
                    <Para ID="Par12">embryonic fibroblast</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NICTH</Term>
                  <Description>
                    <Para ID="Par13">non-islet cell tumor-induced hypoglycemia</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>
                    <Emphasis Type="Italic">Otg1</Emphasis>
                  </Term>
                  <Description>
                    <Para ID="Par14">oocyte testis gene 1</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>
                    <Emphasis Type="Italic">PB</Emphasis>
                  </Term>
                  <Description>
                    <Para ID="Par15">
                      <Emphasis Type="Italic">piggyBac</Emphasis>
                    </Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>shRNA</Term>
                  <Description>
                    <Para ID="Par16">small hairpin RNA</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>TGN</Term>
                  <Description>
                    <Para ID="Par17">trans-Golgi network</Para>
                  </Description>
                </DefinitionListEntry>
              </DefinitionList>
            </AbbreviationGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Guangxue Wang, Rongbo Li and Ying Yang contributed equally to this work</SimplePara>
            </ArticleNote>
            <ArticleNote Type="ESMHint">
              <Heading>Electronic supplementary material</Heading>
              <SimplePara>The online version of this article (doi:<ExternalRef>
                  <RefSource>10.1186/s13578-016-0108-4</RefSource>
                  <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                </ExternalRef>) contains supplementary material, which is available to authorized users.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <Body>
            <Section1 ID="Sec1">
              <Heading>Background</Heading>
              <Para ID="Par18">Glucose is the key source for energy production in mammals. Under normal physiological conditions, the blood glucose level is well regulated by concerted actions of the pancreas, liver, adipose tissue, muscle and brain [<CitationRef CitationID="CR1">1</CitationRef>, <CitationRef CitationID="CR2">2</CitationRef>]. Abnormal glucose homeostasis would result in hyperglycemia or hypoglycemia. Hyperglycemia is the characteristic condition of diabetes, which has becoming a rapidly growing health threat in modern society [<CitationRef CitationID="CR3">3</CitationRef>]. Chronic hyperglycemia causes glycation of proteins or lipids, which causes many of the long-term complications in diabetic patients [<CitationRef CitationID="CR4">4</CitationRef>]. In contrast, since glucose supplies almost all the energy for the brain, hypoglycemia may quickly cause loss of consciousness or even death.</Para>
              <Para ID="Par19">Peptide hormones such as insulin, glucagon, growth hormone and IGF-1 play critical roles in regulating glucose homeostasis [<CitationRef CitationID="CR5">5</CitationRef>–<CitationRef CitationID="CR9">9</CitationRef>]. Being expressed, peptide hormones are packaged in vesicles at the trans-Golgi network (TGN), transported on microtubules toward the plasma membrane and loaded onto an actin/myosin system for distal transport through the actin cortex to just below the plasma membrane. After tethered there, a subpopulation of vesicles are docked and primed to become the readily-releasable pools [<CitationRef CitationID="CR10">10</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>]. Upon stimulation, these vesicles in the readily-releasable pool would immediately fuse to the plasma membrane to release the contents. This process is essential for activity-dependent hormone secretion to mediate various endocrinological functions. Despite of many identified proteins involved in vesicle budding, trafficking, tethering/docking and cargo secretion, the molecular mechanisms and molecules participating peptide hormone secretion remain to be explored.</Para>
              <Para ID="Par20">The oocyte-testis gene 1 (<Emphasis Type="Italic">Otg1</Emphasis>) was originally identified in the RIKEN Mouse Gene Encyclopedia Project [<CitationRef CitationID="CR12">12</CitationRef>]. The full-length transcript has 16 exons that encode a 917-amino acid peptide. The OTG1 protein has several coiled-coil domains that occupy almost half of the peptide. Other than these, no functional motifs have been predicted in OTG1 [<CitationRef CitationID="CR13">13</CitationRef>]. The human homologue of <Emphasis Type="Italic">Otg1</Emphasis> encodes the protein that has been recognized as a cutaneous T-cell lymphoma (CTCL) associated antigen [<CitationRef CitationID="CR14">14</CitationRef>]. Recently, the <Emphasis Type="Italic">C. elegans</Emphasis> homologue of <Emphasis Type="Italic">Otg1</Emphasis> has been reported as a vesicle trafficking regulator in neurons [<CitationRef CitationID="CR15">15</CitationRef>]. Here we report that mouse <Emphasis Type="Italic">Otg1</Emphasis> encodes a protein with prominent Golgi localization. Loss of <Emphasis Type="Italic">Otg1</Emphasis> results in postnatal lethality, aberrant glucose homeostasis and defective hormone secretion in mice. These results revealed an unknown role of <Emphasis Type="Italic">Otg1</Emphasis> in participating hormone secretion and metabolic regulation in mammals.</Para>
            </Section1>
            <Section1 ID="Sec2">
              <Heading>Results</Heading>
              <Section2 ID="Sec3">
                <Heading>Disruption of <Emphasis Type="Italic">Otg1</Emphasis> results in postnatal lethality and growth retardation in mice</Heading>
                <Para ID="Par21">We identified an <Emphasis Type="Italic">Otg1</Emphasis> mutant in a screen for mice bearing metabolic defects [<CitationRef CitationID="CR16">16</CitationRef>]. The mutant carries a <Emphasis Type="Italic">piggyBac</Emphasis> transposon (<Emphasis Type="Italic">PB</Emphasis>) insertion in the eighth exon of <Emphasis Type="Italic">Otg1</Emphasis> (<Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB</Emphasis>
                  </Superscript>) that effectively disrupts gene expression (Fig. <InternalRef RefID="Fig1">1</InternalRef>a). In wild-type animals, <Emphasis Type="Italic">Otg1</Emphasis> proteins can be readily detected in various organs such as the brain, heart, lung, stomach, liver, kidney, pancreas and gut. In tissues from homozygous mutants, <Emphasis Type="Italic">Otg1</Emphasis> expression is no longer detectable (Fig. <InternalRef RefID="Fig1">1</InternalRef>b). Similar changes were also observed by immunofluorescence staining in pancreatic cells and embryonic fibroblasts (MEFs) with different genotypes (Fig. <InternalRef RefID="Fig1">1</InternalRef>c and Additional file <InternalRef RefID="MOESM1">1</InternalRef>: Figure S1). Similar as that of the <Emphasis Type="Italic">C. elegans</Emphasis> homologue, immunofluorescence staining in wild-type pancreatic cells and MEFs revealed co-localization of OTG1 proteins with the Golgi compartment marker Giantin, confirming a Golgi localization of OTG1 in mice (Fig. <InternalRef RefID="Fig1">1</InternalRef>c) [<CitationRef CitationID="CR15">15</CitationRef>, <CitationRef CitationID="CR17">17</CitationRef>].<Figure Category="Standard" Float="Yes" ID="Fig1">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>A PB insertion effectively abolished <Emphasis Type="Italic">Otg1</Emphasis> expression. <Emphasis Type="Bold">a</Emphasis> Schematic representation of the genomic sequence flanking <Emphasis Type="Italic">PB</Emphasis> insertion site in <Emphasis Type="Italic">Otg1</Emphasis>. <Emphasis Type="Italic">White box</Emphasis>: exon. <Emphasis Type="Bold">b</Emphasis> Western blot did not detect OTG1 expression in either E13.5 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> embryos or tissues of P1 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> mice. <Emphasis Type="Bold">c</Emphasis> Immunofluorescence staining showed co-localization of OTG1 protein and Giantin in both pancreatic tissues of MEFs from wild-type mice</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO1">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_108_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
                <Para ID="Par22">Oocyte testis gene 1<Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> animals were born in consistent with a Mendelian pattern of inheritance (Additional file <InternalRef RefID="MOESM2">2</InternalRef>: Table S1). However, 46.5 % (53/114) homozygous <Emphasis Type="Italic">Otg1</Emphasis> mutants could not survive throughout the first day after birth (P1), while others gradually died within the next 30 days. In contrast, 96.4 % (108/112) wild-type and 94.2 % (196/208) heterozygous littermates kept alive at the age of one month (Fig. <InternalRef RefID="Fig2">2</InternalRef>a). The external morphology of mutants died at P1 was apparently normal. In contrast, the most obvious morphological changes of other dead mutants were their small sizes (Fig. <InternalRef RefID="Fig2">2</InternalRef>c). Further analysis showed that <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> individuals had comparable body weight with their littermates both at the end of fetal development (embryonic day 18.5, Additional file <InternalRef RefID="MOESM3">3</InternalRef>: Figure S2C) and at birth (Fig. <InternalRef RefID="Fig2">2</InternalRef>b). Soon after that, the survivors suffered from severe growth retardation. The body weight of <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice increased much slower than that of the wild-type and heterozygous littermates. In fact, homozygous <Emphasis Type="Italic">Otg1</Emphasis> mutants always exhibit lipohypotrophy and usually died before the body weight reaches 5 grams (Fig. <InternalRef RefID="Fig2">2</InternalRef>b, d).<Figure Category="Standard" Float="Yes" ID="Fig2">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Postnatal lethality and growth retardation in <Emphasis Type="Italic">Otg1</Emphasis> mutant mice. <Emphasis Type="Bold">a</Emphasis> Survival curves of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 114), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 208) and wild-type (n = 114) littermates. <Emphasis Type="Bold">b</Emphasis> Body weight curves of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 25), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 38) and wild-type (n = 18) littermates. <Emphasis Type="Bold">c</Emphasis> Representative image showing the body size difference between an <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> and a wild-type mouse at P11. <Emphasis Type="Bold">d</Emphasis> Representative image of the hypodermis histological section of P4 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> and <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>+<Emphasis Type="Italic">/</Emphasis>+</Superscript> mice, showing severe lipodystrophy of the mutant</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO2">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_108_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec4">
                <Heading>
                           <Emphasis Type="Italic">Otg1</Emphasis> mutation leads to impaired glucose homeostasis</Heading>
                <Para ID="Par23">We then explored pathophysiological alterations that may lead to postnatal lethality and growth retardation in <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice. Alcian blue-alizarin red staining revealed normal skeleton structures in <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mutants (Additional file <InternalRef RefID="MOESM3">3</InternalRef>: Figure S2A). This result, along with the normal body weight of newborn animals, suggests that severe embryonic developmental defects, such as abnormal pattern formation, shall not be accounted for postnatal lethality and growth retardation. We often observed milk in the stomach of <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> pups, suggesting that feeding failure is unlikely the reason for growth retardation and lethality (Additional file <InternalRef RefID="MOESM3">3</InternalRef>: Figure S2B).</Para>
                <Para ID="Par24">Given the critical role of glucose in supporting growth, we examined glucose homeostasis in mutant mice. We observed progressively developed hypoglycemia in <Emphasis Type="Italic">Otg1</Emphasis> mutants. The blood glucose level in free–fed <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice was similar as that in the wild-type and heterozygous littermates at birth, then decreased to approximately 25 % blow normal within two days and further dropped to 58 % of that in the wild-type at the age of 11 days (P11) (Fig. <InternalRef RefID="Fig3">3</InternalRef>a, b). Fasted blood glucose levels of P11 <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice were only 47 % of that in the wild-type mice. In intraperitoneal glucose tolerance test (IPGTT), the blood glucose level of P11 <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice changed with the same tendency as that of the wild-type or heterozygous mice, but kept to be approximately 60 % lower at each time point (Fig. <InternalRef RefID="Fig3">3</InternalRef>c). In addition to hypoglycemia, we recorded extremely low level of serum insulin and elevated insulin sensitivity in the mutants. Compared with 0.66 and 0.57 ng/ml of serum insulin detected in wild-type and heterozygous littermates, respectively, ELISA analysis revealed an average insulin concentration of 0.02 ng/ml in P11 homozygotes (Fig. <InternalRef RefID="Fig3">3</InternalRef>d). In the insulin tolerance test (ITT), the blood glucose level of P11 <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice dropped more rapidly than that of the wild-type and heterozygous littermates. In fact, it decreased to a level too low to be detected within 30 min (Fig. <InternalRef RefID="Fig3">3</InternalRef>e). Finally, we observed hypoleptinemia in <Emphasis Type="Italic">Otg1</Emphasis> mutants. Consistent with lipodystrophy, <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice had circulating leptin below detectable level (&lt;0.2 ng/ml) at P11 (Fig. <InternalRef RefID="Fig3">3</InternalRef>f).<Figure Category="Standard" Float="Yes" ID="Fig3">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 3</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Impaired glucose homeostasis in <Emphasis Type="Italic">Otg1</Emphasis> mutant mice. <Emphasis Type="Bold">a</Emphasis> Blood glucose levels of newborn <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (P1: n = 13; P2: n = 10), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (P1: n = 30; P2: n = 30) and wild-type (P1: n = 16; P2: n = 11) littermates. <Emphasis Type="Bold">b</Emphasis> Blood glucose levels of free fed or 2-hour starved <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 10), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 19) and wild-type (n = 10) littermates at P11. <Emphasis Type="Bold">c</Emphasis> Intraperitoneal glucose tolerance test (IPGTT) performance of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 4), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 6) and wild-type (n = 3) littermates at P11. <Emphasis Type="Bold">d</Emphasis> Serum insulin levels of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 10), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 19) and wild-type (n = 10) littermates at P11. <Emphasis Type="Bold">e</Emphasis> Insulin tolerance test (ITT) results of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 4), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 8) and wild-type (n = 5) littermates at P11. <Emphasis Type="Bold">f</Emphasis> Serum leptin levels of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 7), <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                                          <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 5) and wild-type (n = 4) littermates. <Emphasis Type="Bold">g</Emphasis> Serum growth hormone levels of <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 17) and wild-type (n = 15) littermates. <Emphasis Type="Bold">h</Emphasis> Relative IGF-1 expression in <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (P1: n = 5; P2: n = 4) and wild-type (P1: n = 3; P11: n = 5) littermates. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO3">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_108_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
                <Para ID="Par25">Growth retardation, hypoinslulinemia, hypoglycemia and increased insulin sensitivity have been reported in mice with defective growth hormone receptors (GHRs) [<CitationRef CitationID="CR7">7</CitationRef>, <CitationRef CitationID="CR9">9</CitationRef>]. This raises the possibility that growth hormone (GH) signaling is aberrant in <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice. We measured the expressions of GH and its downstream mediator IGF-1. Compared with those of the wild-type littermates, ELISA revealed approximately 35 % reduction of serum GH levels in P11 <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice, while real-time RT-PCR detected 50 and 87 % decrease of hepatic <Emphasis Type="Italic">IGF</Emphasis>-<Emphasis Type="Italic">1</Emphasis> expression in P1 and P11 mutants, respectively (Fig. <InternalRef RefID="Fig3">3</InternalRef>g, h). Taken together, the results above suggest that disruption of <Emphasis Type="Italic">Otg1</Emphasis> leads to impaired glucose homeostasis in mice.</Para>
              </Section2>
              <Section2 ID="Sec5">
                <Heading>
                           <Emphasis Type="Italic">Otg1</Emphasis> mutation leads to aberrant vesicle trafficking</Heading>
                <Para ID="Par26">Given its Golgi localization and the reported role of the <Emphasis Type="Italic">C. elegans</Emphasis> homologue in neurons [<CitationRef CitationID="CR15">15</CitationRef>], <Emphasis Type="Italic">Otg1</Emphasis> is likely to be involved in vesicle trafficking, a process that is critical for protein hormone secretion in mammals. Consistent with this predicted role, we found <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> mice had islet cells 48 % of the sizes of their wild-type littermates (Fig. <InternalRef RefID="Fig4">4</InternalRef>a, b). This is likely the consequence of defective vesicle trafficking rather than the result of smaller body size, since <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> hepatocytes are of similar sizes as those of the <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>+<Emphasis Type="Italic">/PB</Emphasis>
                           </Superscript> animals (Additional file <InternalRef RefID="MOESM4">4</InternalRef>: Figure S3). Electron microscopy also revealed a greatly reduced number of insulin granules in the cytoplasm of mutant β cells (Fig. <InternalRef RefID="Fig4">4</InternalRef>c). To mask the possible effect on insulin secretion from reduced GH signaling in vivo, we isolated islets from newborn mutants and examined their response to glucose challenge by measuring secreted insulin in the culture medium. There was no significant difference between <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> and the wild-type islets when they were provided with basal level (3 mM) of glucose. However, when challenged by 25 mM of glucose for 1 h, the insulin concentration in the culture medium of <Emphasis Type="Italic">Otg1</Emphasis>
                           <Superscript>
                    <Emphasis Type="Italic">PB/PB</Emphasis>
                  </Superscript> islets was only 25 % of that of the wild-type islets (Fig. <InternalRef RefID="Fig4">4</InternalRef>d). Altogether, these results suggest that the smaller islet cells are likely the result of defective vesicle trafficking caused by the <Emphasis Type="Italic">Otg1</Emphasis> mutation.<Figure Category="Standard" Float="Yes" ID="Fig4">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 4</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Decreased <Emphasis Type="Italic">Otg1</Emphasis> expression leads to impaired hormone secretion. <Emphasis Type="Bold">a</Emphasis> H&amp;E staining of pancreas from P11 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> and wild-type littermates. <Emphasis Type="Bold">b</Emphasis> Relative pancreas islet cell sizes of P11 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 31) and wild-type (n = 20) littermates. <Emphasis Type="Bold">c</Emphasis> Scanning EM of islet cells of P6 <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> and wild-type littermates. <Emphasis Type="Italic">White arrows</Emphasis> indicate insulin granules. N: nucleus. G: Golgi. <Emphasis Type="Bold">d</Emphasis> Insulin levels of glucose stimulated insulin secretion (GSIS) after isolation of islets isolated from <Emphasis Type="Italic">Otg1</Emphasis>
                                       <Superscript>
                            <Emphasis Type="Italic">PB/PB</Emphasis>
                          </Superscript> (n = 7) and wild-type (n = 8) littermates at P1. <Emphasis Type="Bold">e</Emphasis> Western blot showed the decreased <Emphasis Type="Italic">Otg1</Emphasis> expression in GH3 cells transfected with small hairpin RNAs, but not scramble shRNAs. GAPHD serves as the loading control. <Emphasis Type="Bold">f</Emphasis> Released growth hormone levels in <Emphasis Type="Italic">Otg1</Emphasis> knockdown cells compared with cells transfected with scramble shRNAs, which is arbitrary set as 1. <Emphasis Type="Bold">g</Emphasis> Growth hormone levels in <Emphasis Type="Italic">Otg1</Emphasis> knockdown cells compared with cells transfected with scramble shRNAs, which is arbitrary set as 1. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO4">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_108_Fig4_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
                <Para ID="Par27">The role of <Emphasis Type="Italic">Otg1</Emphasis> in hormone secretion was further confirmed in rat pituitary GH3 somatolactotropes, a popular model to study GH secretion [<CitationRef CitationID="CR18">18</CitationRef>]. We first knocked down <Emphasis Type="Italic">Otg1</Emphasis> expression with small hairpin RNAs (shRNAs), then measured GH released into the medium within a period of two hours. Compared with cells transfected with scramble shRNAs, shRNA-1 and shRNA-2 transfected cells produced 55 and 58 % less <Emphasis Type="Italic">Otg1</Emphasis> proteins, respectively (Fig. <InternalRef RefID="Fig4">4</InternalRef>e). As expected, shRNA-1 transfection resulted in a reduction of GH content and secretion by 52 and 58 %, respectively, while shRNA-2 transfection resulted in a reduction of GH content and secretion by 43 and 56 %, respectively (Fig. <InternalRef RefID="Fig4">4</InternalRef>f, g).</Para>
                <Para ID="Par28">Decreased hormone secretion in both mouse islet and rat GH3 suggested a critical role of <Emphasis Type="Italic">Otg1</Emphasis> in hormone secretion in mammals. To monitor the effect of <Emphasis Type="Italic">Otg1</Emphasis> on intracellular transport, we used VSVG-mEmerald, a fluorescent reporter that translocates from endoplasmic reticulum to the plasma membrane via the Golgi apparatus at 37 °C [<CitationRef CitationID="CR19">19</CitationRef>]. Live-cell imaging showed that the transportation of VSVG-mEmerald was significantly blocked in <Emphasis Type="Italic">Otg1</Emphasis> knockdown GH3 cells (Additional file <InternalRef RefID="MOESM5">5</InternalRef>: Video S1 and Additional file <InternalRef RefID="MOESM6">6</InternalRef>: Video S2). The average transport speed of VSVG-mEmerald vesicles (n = 110) was 0.068 μm/sec in <Emphasis Type="Italic">shRNA</Emphasis>-<Emphasis Type="Italic">1</Emphasis> treated cells, but 0.186 μm/sec in scramble shRNA treated cells (Fig. <InternalRef RefID="Fig5">5</InternalRef>a). Standard deviations of the transport speed in each <Emphasis Type="Italic">shRNA</Emphasis>-<Emphasis Type="Italic">1</Emphasis> treated cell (n = 11) were also decreased (Fig. <InternalRef RefID="Fig5">5</InternalRef>b and Additional file <InternalRef RefID="MOESM7">7</InternalRef>: Figure S4). These results suggest that <Emphasis Type="Italic">Otg1</Emphasis> is required for vesicle trafficking in mammalian cells.<Figure Category="Standard" Float="Yes" ID="Fig5">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Blocked intracellular transport in <Emphasis Type="Italic">Otg1</Emphasis> knockdown cells. GH3 cells were co-transfected with VSVG-mEmerald and <Emphasis Type="Italic">Otg1</Emphasis> shRNA or scramble shRNA. <Emphasis Type="Bold">a</Emphasis> 
                                       <Emphasis Type="Italic">Scatter plot</Emphasis> showing decreased transport speed of VSVG-mEmerald vesicles in <Emphasis Type="Italic">Otg1</Emphasis> knockdown (<Emphasis Type="Italic">red triangles</Emphasis>) and scramble shRNA treated (<Emphasis Type="Italic">black dots</Emphasis>) GH3 cells. Eleven cells were scored for each group. Ten vesicles were randomly picked from each cell. <Emphasis Type="Bold">b</Emphasis> Scatter plot showing <Emphasis Type="Italic">Otg1</Emphasis> knockdown resulted in decreased standard deviation of transport speed (std speed) and unaltered directionality of VSVG-mEmerald vesicles in each cell. Data of vesicles selected in (<Emphasis Type="Bold">a</Emphasis>) were used for the calculation. <Emphasis Type="Bold">c</Emphasis>, <Emphasis Type="Bold">d</Emphasis> A representative image (<Emphasis Type="Bold">c</Emphasis>) and its close-up (<Emphasis Type="Bold">d</Emphasis>) showing tracked movement of 10 VSVG-mEmerald vesicles (<Emphasis Type="Italic">lines in color</Emphasis>) in scramble shRNA treated GH3 cells. <Emphasis Type="Bold">(e</Emphasis>, <Emphasis Type="Bold">f)</Emphasis> A representative image (<Emphasis Type="Bold">e</Emphasis>) and its close-up (<Emphasis Type="Bold">f</Emphasis>) showing tracked movement of 10 VSVG-mEmerald vesicles (<Emphasis Type="Italic">lines in color</Emphasis>) in <Emphasis Type="Italic">Otg1</Emphasis> knock down GH3 cells. <Emphasis Type="Italic">Scale bars</Emphasis> 5 μm. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO5">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_108_Fig5_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec6">
              <Heading>Discussion</Heading>
              <Para ID="Par29">In the present study, we have shown that <Emphasis Type="Italic">Otg1</Emphasis> encodes a Golgi protein that is required for normal vesicle trafficking in mammalian cells. Disruption of <Emphasis Type="Italic">Otg1</Emphasis> results in growth retardation and postnatal lethality in mice. Various abnormalities related to glucose homeostasis, such as hypoinslulinemia, hypoglycemia, increased insulin sensitivity, decreased serum growth hormone level and reduced hepatic IGF-1 expression, could be observed in mutant animals before death. These results revealed an unknown function <Emphasis Type="Italic">Otg1</Emphasis> in metabolic regulation.</Para>
              <Para ID="Par30">Oocyte testis gene 1 is ubiquitously expressed with a prominent Golgi localization. Almost half of the peptide sequence is occupied by coiled-coil regions with short interruptions. OTG1 is a conserved protein during evolution and the human homologue has been identified as a tumor antigen. These features are reminiscent of those of the golgin coiled-coil proteins, which are known as membrane and cytoskeleton tethers [<CitationRef CitationID="CR20">20</CitationRef>, <CitationRef CitationID="CR21">21</CitationRef>]. Although the C-terminus of OTG1 lacks a transmembrane or a small GTPase interacting signal, which are usually presented in a typical goglin, OTG1 may still be involved in similar intracellular activities by serving as molecular partners of typical golgins. Under this scenario, OTG1 may be involved not only in capturing incoming vesicles, but also in providing specificity to the tethering step.</Para>
              <Para ID="Par31">Hypoglycemia is normal during the first hours of mammalian life. However, prolonged neonatal hypoglycemia would cause long-term neuronal deficits [<CitationRef CitationID="CR22">22</CitationRef>]. In contrast to extensively recognized hyperinsulinemic hypoglycemia, hypoinsunlinemic hypoglycemia is an extrememly rare condition in human. Limited cases of hypoinsunlinemic hypoglycemia are usually related to impaired insulin signaling pathway. For example, a hyperactive mutation of <Emphasis Type="Italic">AKT</Emphasis>2, the gene required for insulin-induced translocation of GLUT4 to the plasma membrane, caused hypoinsunlinemic hypoglycemia in four patients [<CitationRef CitationID="CR23">23</CitationRef>, <CitationRef CitationID="CR24">24</CitationRef>]. On the other hand, non-islet cell tumor-induced hypoglycemia (NICTH) is caused by the secretion of incompletely processed precursors of IGF-II, which has an insulin-like hypoglycaemic activity [<CitationRef CitationID="CR25">25</CitationRef>]. We have shown that disruption of <Emphasis Type="Italic">Otg1</Emphasis> caused hypoinsunlinemic hypoglycemia in mice, which implies a possible role of <Emphasis Type="Italic">Otg1</Emphasis> mutations in human patients. The fact that <Emphasis Type="Italic">Otg1</Emphasis> mutation blocked vesicle trafficking also suggests a new etiology of this rarely observed disease condition. Examine other regulators of vesicle trafficking in human patients may identify more causative mutations of hypoinsunlinemic hypoglycemia in the future.</Para>
              <Para ID="Par32">The mechanism through which <Emphasis Type="Italic">Otg1</Emphasis> modulates vesicle trafficking remains to be investigated. The <Emphasis Type="Italic">C. elegans</Emphasis> homologue of <Emphasis Type="Italic">Otg1</Emphasis> works as a partner of Rab-2 and Rund-1 in regulating neuronal vesicle trafficking [<CitationRef CitationID="CR15">15</CitationRef>]. However, mutations of the homologues of <Emphasis Type="Italic">Rab</Emphasis>-<Emphasis Type="Italic">2</Emphasis> (<Emphasis Type="Italic">Rab</Emphasis>-<Emphasis Type="Italic">2a and Rab</Emphasis>-<Emphasis Type="Italic">2b</Emphasis>) or <Emphasis Type="Italic">Rund</Emphasis>-<Emphasis Type="Italic">1</Emphasis> (<Emphasis Type="Italic">Rundc</Emphasis>-<Emphasis Type="Italic">1</Emphasis>) showed different phenotypes from that of <Emphasis Type="Italic">Otg1</Emphasis> mutants in mice [<CitationRef CitationID="CR26">26</CitationRef>, <CitationRef CitationID="CR27">27</CitationRef>]. Unlike the <Emphasis Type="Italic">C. elegans</Emphasis> mutant, <Emphasis Type="Italic">Otg1</Emphasis>
                        <Superscript>
                  <Emphasis Type="Italic">PB/PB</Emphasis>
                </Superscript> mice did not show gross behavioral defects. The observation that <Emphasis Type="Italic">Otg1</Emphasis>
                        <Superscript>
                  <Emphasis Type="Italic">PB/PB</Emphasis>
                </Superscript> pups are capable of sucking milk suggests they may have normal neuronal functions (Additional file <InternalRef RefID="MOESM3">3</InternalRef>: Figure S2B). In addition, the human orthologue of <Emphasis Type="Italic">Otg1</Emphasis> is a tumor antigen. Thus, further studies of <Emphasis Type="Italic">Otg1</Emphasis> may not only shed light on the mechanisms of vesicle trafficking in mammals, but also contribute to the study of related diseases such as metabolic abnormalities or cancer.</Para>
            </Section1>
            <Section1 ID="Sec7">
              <Heading>Conclusions</Heading>
              <Para ID="Par33">Our results revealed an essential role of <Emphasis Type="Italic">Otg1</Emphasis> in vesicle trafficking, which is critical for peptide hormone secretion, metabolic regulation and postnatal survival in mice.</Para>
            </Section1>
            <Section1 ID="Sec8">
              <Heading>Methods</Heading>
              <Section2 ID="Sec9">
                <Heading>Mice</Heading>
                <Para ID="Par34">All animal experiments were performed in accordance with protocols approved by the Animal Care and Use Committee of the Institute of Developmental Biology and Molecular Medicine (IDM), Fudan University. The <Emphasis Type="Italic">Otg1</Emphasis> mutant strain (H66eR12) was generated on the FVB/NJ background and maintained on 12/12-hour light/dark cycles. The <Emphasis Type="Italic">Otg1</Emphasis> mutation carried by H66eR12 was induced with a <Emphasis Type="Italic">piggyBac</Emphasis> transposon (<Emphasis Type="Italic">PB</Emphasis>) insertion in the eighth exon. Mapping information of the PB insertion in <Emphasis Type="Italic">Otg1</Emphasis> and the mutant genotyping protocol could be found from the PBmice database [<CitationRef CitationID="CR16">16</CitationRef>]. All assays were performed in a mixed population of both males and females.</Para>
              </Section2>
              <Section2 ID="Sec10">
                <Heading>Metabolic assays</Heading>
                <Para ID="Par35">Blood glucose levels were analyzed with Glucometer Elite (LifeScan). For glucose tolerant tests (GTTs), animals were fasted two hours before receiving intraperitoneal injection of 20 % glucose saline solutions (2 g glucose per kg body weight). Tail vein blood was then sampled at 0, 15, 30, 60, 90 and 120 min after injection for blood glucose tests. For insulin tolerance tests (ITTs), 2-hour fasted mice received an intraperitoneal injection of insulin (Humulin, Lilly) (0.75 U/kg body weight), then had tail vein blood glucose levels measured at 0, 15, 30, 45 and 60 min later. ELISA was performed following the manufacturer’s protocol to measure serum insulin (Crystal Chem Inc.), leptin (Crystal Chem Inc.) and growth hormone (Millipore) concentrations. All samples were collected from female mice at the age of P11.</Para>
              </Section2>
              <Section2 ID="Sec11">
                <Heading>Islet culture and glucose stimulated insulin secretion (GSIS)</Heading>
                <Para ID="Par36">Pancreatic islets were isolated by collagenase perfusion in situ, digested for 28 min and then purified by single layer histopaque (Sigma). Isolated islets from different mice were mixed and cultured in RPMI 1640 medium supplemented with 11 mM glucose, 7.5 % FCS and 10 mM HEPES (Sigma). For GSIS assay, islets were washed in PBS and incubated in a 96-well plate with glucose-free Krebs–Ringer bicarbonate (KRB) medium (125 mM NaCl, 4.74 mM KCl, 1 mM CaCl<Subscript>2</Subscript>, 1.2 mM KH<Subscript>2</Subscript>PO<Subscript>4</Subscript>, 1.2 mM MgSO<Subscript>4</Subscript>, 5 mM NaHCO<Subscript>3</Subscript>, 25 mM HEPES, pH 7.4, with 0.1 % BSA) at 37 °C for 30 min, then incubated in KRB containing 3 mM or 25 mM glucose at 37 °C for 30 min with 5 islets per well. The amount of insulin released into the incubation medium in each well was assayed using ELISA (Crystal Chem Inc.). At least 5 wells were examined for each genotype with each glucose concentration.</Para>
              </Section2>
              <Section2 ID="Sec12">
                <Heading>Western blot</Heading>
                <Para ID="Par37">Protein extraction was prepared with the RIPA lysis buffer and quantified with the BCA Protein Assay Kit (Pierce). Equal amounts of samples were separated by SDS/PAGE, transferred onto PVDF membranes (Millipore) and immunoblotted following standard protocols. The antibodies used were: rabbit anti-OTG1 (Sigma HPA018019, 1:1000), mouse anti-GAPDH (KangCheng Biotech KC-5G4, 1:10,000) rabbit anti-β-actin (Santa Cruz sc-1616-R, 1:2000), goat anti-mouse IgG-HRP (Santa Cruz sc-2005, 1:5000) and goat anti-rabbit IgG-HRP (Santa Cruz sc-2004, 1:5000).</Para>
              </Section2>
              <Section2 ID="Sec13">
                <Heading>Histology and immunohistochemistry</Heading>
                <Para ID="Par38">Frozen sections were prepared by fixing tissues overnight in 4 % paraformaldehyde, followed by cryoprotection in 30 % sucrose at 4 °C for two days and sectioning with given thickness for histological and immunofluorescence analysis. For morphological analysis, Section (5 μm) were stained with hematoxylin and eosin to have images acquired with a Leica DMRXA2 microscope. For immunofluorescence analysis, Section (6–8 μm) were treated following the standard protocol with following antibodies: rabbit anti-OTG1 (Sigma HPA018019, 1:1000), Alexa 488 conjugated rabbit-anti-Giantin (Covance A488-114L, 1:1000), rabbit anti-insulin (Santa Cruz sc-9168, 1:1000), goat anti-glucagon (Santa Cruz sc-7780, 1:1000), donkey anti-goat IgG-FITC (Chemicon AP180F, 1:2000), donkey anti-rabbit IgG-Cy3 (Millipore AP182C, 1:2000).</Para>
              </Section2>
              <Section2 ID="Sec14">
                <Heading>Electron microscopy</Heading>
                <Para ID="Par39">Pancreas tissues were fixed in a fresh fixative solution consisting of 2 % glutaraldehyde and 4 % paraformaldehyde, postfixed with 1 % osmium tetroxide in phosphate buffer at 4 °C and dehydrated in ascending concentrations of methanol and propylenoxide before being embedded in Epoxy resin. Ultra-thin sections were prepared using a Reichert ultramicrotome, contrasted with uranyl acetate and lead citrate and examined under a Philips CM120 electron microscope.</Para>
              </Section2>
              <Section2 ID="Sec15">
                <Heading>Cell culture and live imaging</Heading>
                <Para ID="Par40">Rat pituitary GH3 cells were cultured at 37 °C in a humidified atmosphere containing 95 % air and 5 % CO<Subscript>2</Subscript>. The culture medium was DMEM supplemented with 10 % fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin. GH3 cells were transfected with small hairpin RNA (shRNA) constructs (Sigma-Aldrich) or the VSVG-mEmerald plasmid (modified from Addgene plasmid #31947) with Lipofectamine 2000 (Invitrogen). For growth hormone secretion assay, cells were transferred to serum free medium 48 h after transfection and incubated for 2 h before ELISA. Live cell confocal images were acquired 48 h after transfection, using spinning disk confocal scan head (CSU-X/M2 N, Yokogawa) attached to an inverted microscope (IX-81, Olympus) and an EMCCD camera (DU897BV, Andor) controlled by Micro-Manager software. Images (512 × 512 pixels, voxel size 0.0946 μm/pixel) were taken every 0.5 s for 400 frames. Live images were analyzed in NIH ImageJ with the MTrackJ plugin. VSVG containing vesicles (10/cell) were randomly selected in 11 <Emphasis Type="Italic">Otg1</Emphasis> knockdown cells and 11 scramble shRNAs treated cells. Directionality of each vesicle was defined as its real transport distance divided by linear distance between the start and end positions.</Para>
              </Section2>
              <Section2 ID="Sec16">
                <Heading>Statistics</Heading>
                <Para ID="Par41">GSIS data were compared by two-way ANOVA analysis. All other data were compared by unpaired two-tailed Student’s <Emphasis Type="Italic">t</Emphasis> test. Results were shown as mean ± SEM. <Emphasis Type="Italic">P</Emphasis> &lt; 0.05 was considered statistically significant.</Para>
              </Section2>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/13578_2016_Article_108.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Acknowledgments>
              <Heading>Authors’ contributions</Heading>
              <SimplePara>GW characterized the physiological and metabolic alterations of the animals, participated in islet and cell culture experiments. RL participated in physiological and metabolic phenotyping, carried out molecular genetic experiments. YY and LC characterized vesicle trafficking alterations in GH3 cells. SD mapped the mutations and initially identified the lethality phenotype. MH and TX participated in the design of the study and helped to analyze the results. XW conceived of the study and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</SimplePara>
              <FormalPara ID="FPar1" RenderingStyle="Style1">
                <Heading>Acknowledgements</Heading>
                <Para ID="Par42">We thank Dr. Lei Xue for stimulating discussions, Xiaoping Huang, Guoying Ma, Yanfeng Tan, Guicheng Wang and Yanqian Xia for technical assistance.</Para>
              </FormalPara>
              <FormalPara ID="FPar2" RenderingStyle="Style1">
                <Heading>Competing interests</Heading>
                <Para ID="Par43">The authors declare that they have no competing interests.</Para>
              </FormalPara>
              <FormalPara ID="FPar3" RenderingStyle="Style1">
                <Heading>Ethics approval and consent to participate</Heading>
                <Para ID="Par44">All animal procedures applied in this article have been approved by the Animal Care and Use Committee of the Institute of Developmental Biology and Molecular Medicine, Fudan University, Shanghai, China.</Para>
              </FormalPara>
              <FormalPara ID="FPar4" RenderingStyle="Style1">
                <Heading>Sources of funding</Heading>
                <Para ID="Par45">This work was supported in part by grants from Chinese Hi-tech Research and Development Project (863) [2014AA021104], Natural Science Foundation of China (NSFC) [81170789, 81570756] and Shanghai Municipal Government (15XD1500500 and 12431900100). YY has been supported by the Fudan Undergraduate Research Opportunities Program (FDUROP) and the National Top Talent Undergraduate Training Program (NTTUTP). MH and TX are Howard Hughes Medical Institute investigators.</Para>
              </FormalPara>
              <FormalPara ID="FPar5" RenderingStyle="Style1">
                <Heading>Availability of data and materials</Heading>
                <Para ID="Par46">Not applicable,because we do not have any readily reproducible materials in the manuscript, no new software, no databases and relevant raw data are already included in the text and figures for the reviewers.</Para>
              </FormalPara>
            </Acknowledgments>
            <Appendix ID="App1" OutputMedium="Online">
              <Section1 ID="Sec17">
                <Heading>Additional files</Heading>
                <Para>
                  <MediaObject ID="MOESM1">
                    <DataObject FileRef="MediaObjects/13578_2016_108_MOESM1_ESM.pdf">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 1: Figure S1.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> 
                                          <Emphasis Type="Italic">Otg1</Emphasis> expression is disrupted by the PB insertion. In contrast to Fig. <InternalRef RefID="Fig1">1</InternalRef>c, immunofluorescence staining showed Giantin (green) but not <Emphasis Type="Italic">Otg1</Emphasis> (red) signals in pancreatic tissues and MEFs from <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> mice.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </DataObject>
                  </MediaObject>
                  <MediaObject ID="MOESM2">
                    <DataObject FileRef="MediaObjects/13578_2016_108_MOESM2_ESM.xlsx">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 2: Table S1.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> Genotypes of new born animals.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </DataObject>
                  </MediaObject>
                  <MediaObject ID="MOESM3">
                    <DataObject FileRef="MediaObjects/13578_2016_108_MOESM3_ESM.pdf">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 3: Figure S2.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> 
                                          <Emphasis Type="Italic">Otg1</Emphasis> mutant mice have no severe developmental defects. <Emphasis Type="Bold">(A)</Emphasis> Alcian blue-alizarin red staining of P6 <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>+<Emphasis Type="Italic">/PB</Emphasis>
                                          </Superscript> and <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> mice. <Emphasis Type="Bold">(B)</Emphasis> Representative image showing P6 wild-type and <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> littermates, with sucked milk in the stomach. <Emphasis Type="Bold">(C)</Emphasis> Average body weight of <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> (n = 6), <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                                            <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 15) and wild-type (n = 15) littermates at E18.5.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </DataObject>
                  </MediaObject>
                  <MediaObject ID="MOESM4">
                    <DataObject FileRef="MediaObjects/13578_2016_108_MOESM4_ESM.pdf">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 4: Figure S3.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> 
                                          <Emphasis Type="Italic">Otg1</Emphasis> mutation does not affect hepatocyte size. <Emphasis Type="Bold">(A)</Emphasis> H&amp;E staining of liver sections from P11 <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> and Otg1<Superscript>
                                            <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> littermates. <Emphasis Type="Bold">(B)</Emphasis> Relative hepatocytes size of P11 <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                              <Emphasis Type="Italic">PB/PB</Emphasis>
                            </Superscript> (n = 3) and <Emphasis Type="Italic">Otg1</Emphasis>
                                          <Superscript>
                                            <Emphasis Type="Italic">PB/</Emphasis>+</Superscript> (n = 4) littermates.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </DataObject>
                  </MediaObject>
                  <MediaObject ID="MOESM5">
                    <VideoObject FileRef="MediaObjects/13578_2016_108_MOESM5_ESM.avi">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 5: Video S1.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> GH3 cells co-transfected with VSVG-mEmerald and scramble shRNA.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </VideoObject>
                  </MediaObject>
                  <MediaObject ID="MOESM6">
                    <VideoObject FileRef="MediaObjects/13578_2016_108_MOESM6_ESM.avi">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 6: Video S2.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> GH3 cells co-transfected with VSVG-mEmerald and <Emphasis Type="Italic">Otg1</Emphasis> shRNA-1.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </VideoObject>
                  </MediaObject>
                  <MediaObject ID="MOESM7">
                    <DataObject FileRef="MediaObjects/13578_2016_108_MOESM7_ESM.pdf">
                      <Caption Language="En">
                        <CaptionContent>
                          <SimplePara>
                                          <ExternalRef>
                              <RefSource>
                                <Emphasis Type="Bold">Additional file 7: Figure S4.</Emphasis>
                              </RefSource>
                              <RefTarget Address="10.1186/s13578-016-0108-4" TargetType="DOI"/>
                            </ExternalRef> 
                                          <Emphasis Type="Italic">Otg1</Emphasis> knockdown blocks vesicle transportation in GH3 cells. <Emphasis Type="Bold">(A)</Emphasis> Unaltered directionality between <Emphasis Type="Italic">Otg1</Emphasis> knockdown (red x) and scramble shRNA treated (black crosses) GH3 cells shown in Fig. <InternalRef RefID="Fig5">5</InternalRef>b. <Emphasis Type="Bold">(B)</Emphasis> Decreased standard deviation of transport speed of cells shown in Fig. <InternalRef RefID="Fig5">5</InternalRef>b. ***p &lt; 0.005.</SimplePara>
                        </CaptionContent>
                      </Caption>
                    </DataObject>
                  </MediaObject>
                </Para>
              </Section1>
            </Appendix>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Tirone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FC</Initials>
                    <FamilyName>Brunicardi</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Overview of glucose regulation</ArticleTitle>
                  <JournalTitle>World J Surg</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>461</FirstPage>
                  <LastPage>467</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M3kt1ertQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11344399</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/s002680020338</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Tirone TA, Brunicardi FC. Overview of glucose regulation. World J Surg. 2001;25(4):461–7.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Herman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BB</Initials>
                    <FamilyName>Kahn</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony</ArticleTitle>
                  <JournalTitle>J Clin Investig</JournalTitle>
                  <VolumeID>116</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>1767</FirstPage>
                  <LastPage>1775</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28XmvV2ltL8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16823474</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1483149</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1172/JCI29027</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Investig. 2006;116(7):1767–75.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PV</Initials>
                    <FamilyName>Roder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Han</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Pancreatic regulation of glucose homeostasis</ArticleTitle>
                  <JournalTitle>Exp Mol Med</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>e219</FirstPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC28Xjs1yjsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26964835</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>4892884</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roder PV, Wu B, Liu Y, Han W. Pancreatic regulation of glucose homeostasis. Exp Mol Med. 2016;48:e219.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ahmed</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Advanced glycation endproducts–role in pathology of diabetic complications</ArticleTitle>
                  <JournalTitle>Diabetes Res Clin Pract</JournalTitle>
                  <VolumeID>67</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>3</FirstPage>
                  <LastPage>21</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtFGhsb7I</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15620429</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ahmed N. Advanced glycation endproducts–role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67(1):3–21.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Duvillie</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Phenotypic alterations in insulin-deficient mutant mice</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>5137</FirstPage>
                  <LastPage>5140</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjtlemtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9144203</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>24644</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1073/pnas.94.10.5137</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Duvillie B, et al. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci USA. 1997;94(10):5137–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Vuguin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation</ArticleTitle>
                  <JournalTitle>Endocrinology</JournalTitle>
                  <VolumeID>147</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>3995</FirstPage>
                  <LastPage>4006</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xpt1Sjtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16627579</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>4287247</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1210/en.2005-1410</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Vuguin PM, et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology. 2006;147(9):3995–4006.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <IssueID>24</IssueID>
                  <FirstPage>13215</FirstPage>
                  <LastPage>13220</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnvFamt70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9371826</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>24289</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1073/pnas.94.24.13215</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Zhou Y, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94(24):13215–20.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Lupu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Terwilliger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GV</Initials>
                    <FamilyName>Segre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Efstratiadis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth</ArticleTitle>
                  <JournalTitle>Dev Biol</JournalTitle>
                  <VolumeID>229</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>141</FirstPage>
                  <LastPage>162</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXptVygtLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11133160</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1006/dbio.2000.9975</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229(1):141–62.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice</ArticleTitle>
                  <JournalTitle>Am J Physiol Endocrinol Metab</JournalTitle>
                  <VolumeID>287</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>E405</FirstPage>
                  <LastPage>E413</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvVejtbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15138153</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1152/ajpendo.00423.2003</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Liu JL, et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2004;287(3):E405–13.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Michael</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Cai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Xiong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ouyang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RH</Initials>
                    <FamilyName>Chow</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Mechanisms of peptide hormone secretion</ArticleTitle>
                  <JournalTitle>Trends Endocrinol Metab TEM</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>408</FirstPage>
                  <LastPage>415</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xht1eqt7%2FM</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17084640</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.tem.2006.10.011</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Michael DJ, Cai H, Xiong W, Ouyang J, Chow RH. Mechanisms of peptide hormone secretion. Trends Endocrinol Metab TEM. 2006;17(10):408–15.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YP</Initials>
                    <FamilyName>Loh</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">How peptide hormone vesicles are transported to the secretion site for exocytosis</ArticleTitle>
                  <JournalTitle>Mol Endocrinol</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>2583</FirstPage>
                  <LastPage>2595</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1cXhsVKgt7jE</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18669645</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2626200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Park JJ, Loh YP. How peptide hormone vesicles are transported to the secretion site for exocytosis. Mol Endocrinol. 2008;22(12):2583–95.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kawai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Functional annotation of a full-length mouse cDNA collection</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>409</VolumeID>
                  <IssueID>6821</IssueID>
                  <FirstPage>685</FirstPage>
                  <LastPage>690</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11217851</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kawai J, et al. Functional annotation of a full-length mouse cDNA collection. Nature. 2001;409(6821):685–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Oduru</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Gene discovery in the hamster: a comparative genomics approach for gene annotation by sequencing of hamster testis cDNAs</ArticleTitle>
                  <JournalTitle>BMC Genom</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>22</FirstPage>
                </BibArticle>
                <BibUnstructured>Oduru S, et al. Gene discovery in the hamster: a comparative genomics approach for gene annotation by sequencing of hamster testis cDNAs. BMC Genom. 2003;4(1):22.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TB</Initials>
                    <FamilyName>Hartmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Thiel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Dummer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Schadendorf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Eichmuller</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma</ArticleTitle>
                  <JournalTitle>Br J Dermatol</JournalTitle>
                  <VolumeID>150</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>252</FirstPage>
                  <LastPage>258</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXivFGqurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>14996095</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1365-2133.2004.05651.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Hartmann TB, Thiel D, Dummer R, Schadendorf D, Eichmuller S. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma. Br J Dermatol. 2004;150(2):252–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ailion</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Two Rab2 interactors regulate dense-core vesicle maturation</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>167</FirstPage>
                  <LastPage>180</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC2cXls1Kmsbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24698274</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3997996</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.neuron.2014.02.017</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Ailion M, et al. Two Rab2 interactors regulate dense-core vesicle maturation. Neuron. 2014;82(1):167–80.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibUnstructured>PiggyBac Mutagenesis Information Center. <ExternalRef>
                    <RefSource>http://www.idmshanghai.cn/PBmice/</RefSource>
                    <RefTarget Address="http://www.idmshanghai.cn/PBmice/" TargetType="URL"/>
                  </ExternalRef>. Accessed 21 Nov. 2012.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Linstedt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Hauri</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa</ArticleTitle>
                  <JournalTitle>Mol Biol Cell</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>679</FirstPage>
                  <LastPage>693</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhsFKqtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7691276</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>300978</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1091/mbc.4.7.679</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Linstedt AD, Hauri HP. Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell. 1993;4(7):679–93.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Yamashita</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>270</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>770</FirstPage>
                  <LastPage>774</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXjtFKku7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7822309</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yamashita H, et al. A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta. J Biol Chem. 1995;270(2):770–4.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Toomre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Keller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>White</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Olivo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Simons</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Dual-color visualization of trans-Golgi network to plasma membrane traffic along microtubules in living cells</ArticleTitle>
                  <JournalTitle>J Cell Sci</JournalTitle>
                  <VolumeID>112</VolumeID>
                  <IssueID>Pt 1</IssueID>
                  <FirstPage>21</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXpvFOkuw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9841901</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Toomre D, Keller P, White J, Olivo JC, Simons K. Dual-color visualization of trans-Golgi network to plasma membrane traffic along microtubules in living cells. J Cell Sci. 1999;112(Pt 1):21–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AK</Initials>
                    <FamilyName>Gillingham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Munro</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Finding the Golgi: golgin coiled-coil proteins show the way</ArticleTitle>
                  <JournalTitle>Trends Cell Biol</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>399</FirstPage>
                  <LastPage>408</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC28XjtFOntbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26972448</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.tcb.2016.02.005</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Gillingham AK, Munro S. Finding the Golgi: golgin coiled-coil proteins show the way. Trends Cell Biol. 2016;26(6):399–408.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Witkos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lowe</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">The Golgin Family of Coiled-Coil Tethering Proteins</ArticleTitle>
                  <JournalTitle>Front Cell Dev Biol</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>86</FirstPage>
<Occurrence Type="DOI">
<Handle>10.3389/fcell.2015.00086</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Witkos TM, Lowe M. The Golgin Family of Coiled-Coil Tethering Proteins. Front Cell Dev Biol. 2016;11(3):86.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DH</Initials>
                    <FamilyName>Adamkin</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Neonatal hypoglycemia</ArticleTitle>
                  <JournalTitle>Curr Opin Pediatr</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>150</FirstPage>
                  <LastPage>155</LastPage>
                  <Occurrence Type="PID">
                    <Handle>26780301</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1097/MOP.0000000000000319</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Adamkin DH. Neonatal hypoglycemia. Curr Opin Pediatr. 2016;28(2):150–5.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VB</Initials>
                    <FamilyName>Arya</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia</ArticleTitle>
                  <JournalTitle>J Clin Endocrinol Metab.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>391</FirstPage>
                  <LastPage>394</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC2cXis1ems7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24285683</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Arya VB, et al. Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia. J Clin Endocrinol Metab. 2014;99(2):391–4.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hussain</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">An activating mutation of AKT2 and human hypoglycemia</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>334</VolumeID>
                  <IssueID>6055</IssueID>
                  <FirstPage>474</FirstPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3MXhtlKjtrrJ</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21979934</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3204221</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1126/science.1210878</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Hussain K, et al. An activating mutation of AKT2 and human hypoglycemia. Science. 2011;334(6055):474.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dutta</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Non-islet cell tumor-induced hypoglycemia: a report of five cases and brief review of the literature</ArticleTitle>
                  <JournalTitle>Endocrinol Diabetes Metab Case Rep</JournalTitle>
                  <VolumeID>2013</VolumeID>
                  <FirstPage>130046</FirstPage>
                  <Occurrence Type="PID">
                    <Handle>24616774</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3922193</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1530/EDM-13-0046</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Dutta P, et al. Non-islet cell tumor-induced hypoglycemia: a report of five cases and brief review of the literature. Endocrinol Diabetes Metab Case Rep. 2013;2013:130046.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BP</Initials>
                    <FamilyName>Zambrowicz</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <IssueID>24</IssueID>
                  <FirstPage>14109</FirstPage>
                  <LastPage>14114</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14610273</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>283554</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1073/pnas.2336103100</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Zambrowicz BP, et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA. 2003;100(24):14109–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibUnstructured>(MGP) MGIatWTSIMGP (2011) Obtaining and loading phenotype annotations from the Wellcome Trust Sanger Institute (WTSI) Mouse Resources Portal. <Emphasis Type="Italic">Database Release</Emphasis>.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
